PLAUR and neoplasm: This work supports the rationale for targeting uPAR-positive breast cancer cells, using N-AI-loaded PAI-2-functionalized liposomes, and provides a basis for the further development of liposomes that can target heterogeneous tumor cells within the TNBC subtype, in which uPAR was shown to play a key role in driving metastasis.